DEFLAZACORT TABLETS

DEFLAZACORT TABLETS Specification

Dosage Form
Tablet

Dosage
6 mg, 12 mg, 18 mg

Storage
Store below 30C, protect from moisture and light

Molecular Formula
C25H31NO6

Grade
Pharmaceutical Grade

Medicine Type
Allopathic

Indication
Treatment of inflammation, autoimmune disorders, Duchenne muscular dystrophy

Salt Composition
Deflazacort

CAS No
13649-05-9

Expiration Date
24 months from manufacturing date

Assay
98% - 102%

Usage
Used as an anti-inflammatory and immunosuppressant

Origin of Medicine
India

Appearance
White to off-white, crystalline powder

Pacakaging (Quantity Per Box)
10 tablets per blister, 10 blisters per box

Brand Name
Generic / Available as various brands

Country of Export
India

Pack Type
Blister Pack

Regulatory Approvals
Available with export documentation and COA

Therapeutic Class
Corticosteroids

Contraindications
Hypersensitivity to Deflazacort, systemic fungal infections

Shelf Life
2 Years

Prescription Requirement
Prescription Only

Adverse Effects
May cause weight gain, fluid retention, mood changes

Clinical Pharmacology
Reduces inflammation via inhibition of inflammatory mediators

Route of Administration
Oral

About DEFLAZACORT TABLETS

DEFLAZACORT TABLETS are an ineffable choice for those seeking the latest in corticosteroid therapy. Manufactured under illustrious standards in India, these tablets are available as various popular brands at the best price. With the best pharmaceutical grade (CAS No: 13649-05-9) and potency (assay: 98%-102%), each unit is designed to offer superior anti-inflammatory and immunosuppressive action. Oral administration guarantees convenience, while comprehensive export documentation and COA ensure regulatory compliance. With a two-year shelf life and careful packaging, quality remains uncompromised. Prescription-only supply guarantees safe usage for inflammation and autoimmune disorders.

Competitive Advantages and Key Applications

DEFLAZACORT TABLETS are highly valued for their illustrious efficacy in managing inflammation, autoimmune disorders, and Duchenne muscular dystrophy. Their best-in-class safety profile, competitive pricing, and reliable manufacturing make them a popular choice for healthcare practitioners. Typically used by adults and children requiring corticosteroid therapy, they serve both general anti-inflammatory and specific immunosuppressant needs. The tablets offer stable shelf life and precise dosage, ensuring dependable therapeutic outcomes.

Main Export Markets, Order Process, and Delivery Efficiency

These tablets enjoy remarkable market value in export markets across Asia, Africa, and Latin America. Order completion is streamlined, with flexible payment terms supporting various business models. Upon successful order placement, delivery is prompt and reliable, aligning with the export documentation and COA requirements. Packaging safeguards the product during transit, making delivery efficient and ensuring product integrity upon arrival to healthcare providers worldwide.

FAQ's of DEFLAZACORT TABLETS:

Q: How should DEFLAZACORT TABLETS be used for optimal results?

A: DEFLAZACORT TABLETS should be taken orally as prescribed by your healthcare provider, with the dosage tailored to your specific medical condition. Follow your doctor's instructions for best outcomes.

Q: What are the key therapeutic benefits of using Deflazacort?

A: Deflazacort provides significant reduction in inflammation and is effective in treating autoimmune disorders and Duchenne muscular dystrophy, making it a popular corticosteroid for various indications.

Q: When should DEFLAZACORT TABLETS be avoided?

A: These tablets should not be used by individuals with known hypersensitivity to Deflazacort or those suffering from systemic fungal infections.

Q: Where are DEFLAZACORT TABLETS primarily manufactured and exported from?

A: They are manufactured in India, adhering to illustrious pharmaceutical standards, and exported globally with all requisite documentation, including a Certificate of Analysis (COA).

Q: What adverse effects might occur during Deflazacort therapy?

A: Some common adverse effects include weight gain, fluid retention, and mood changes. Immediate consultation with a physician is advised if severe side effects occur.

Q: How is regulatory compliance ensured in the export process?

A: Each batch comes with export documentation and a Certificate of Analysis, ensuring that regulatory and quality benchmarks are consistently met during the export process.

Tell us about your requirement